Comment
|
Two enzymes are mainly responsible for citrulline synthesis, corresponding to the two main metabolic pathways in which it is involved ornithine carbamoyltransferase (OCT, EC 2.1.3.3) and NO-synthase (NOS, EC 1.14.13.39, including all its iso-enzymes).
|
Formal Description Interaction-ID: 66716
|
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
Two enzymes are mainly responsible for citrulline synthesis, corresponding to the two main metabolic pathways in which it is involved ornithine carbamoyltransferase (OCT, EC 2.1.3.3) and NO-synthase (NOS, EC 1.14.13.39, including all its iso-enzymes).
|
Formal Description Interaction-ID: 66717
|
|
Drugbank entries
|
Show/Hide entries for
NOS2
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01110
|
|
Drugbank
DB01234
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02462
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
Drugbank
DB06879
|
5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H- ...
|
Drugbank
DB06916
|
N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-( ...
|
Drugbank
DB07002
|
4-({4-[(4-methoxypyridin-2-yl)amino]pipe ...
|
Drugbank
DB07003
|
(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1 ...
|
Drugbank
DB07007
|
(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7 ...
|
Drugbank
DB07008
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07011
|
(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4 ...
|
Drugbank
DB07029
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07306
|
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07318
|
N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQU ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07389
|
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL ...
|
Drugbank
DB07405
|
1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFL ...
|
Drugbank
DB08214
|
4-(1H-IMIDAZOL-1-YL)PHENOL
|
Drugbank
DB08750
|
1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H ...
|
Drugbank
DB08814
|
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
|
|
Comment
|
Two enzymes are mainly responsible for citrulline synthesis, corresponding to the two main metabolic pathways in which it is involved ornithine carbamoyltransferase (OCT, EC 2.1.3.3) and NO-synthase (NOS, EC 1.14.13.39, including all its iso-enzymes).
|
Formal Description Interaction-ID: 66718
|
|
Drugbank entries
|
Show/Hide entries for
NOS3
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB00360
|
|
Drugbank
DB01110
|
|
Drugbank
DB01686
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01833
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02048
|
1,2,4-Triazole-Carboxamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02141
|
S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl)) ...
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02335
|
|
Drugbank
DB02589
|
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02911
|
2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydro ...
|
Drugbank
DB02979
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetra ...
|
Drugbank
DB02994
|
Hydroxydimethylarsine Oxide
|
Drugbank
DB03014
|
|
Drugbank
DB03065
|
7-Nitroindazole-2-Carboxamidine
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03305
|
N5-Iminoethyl-L-Ornithine
|
Drugbank
DB03332
|
5,6-Cyclic-Tetrahydropteridine
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03910
|
S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl)) ...
|
Drugbank
DB03918
|
6s-5,6,7,8-Tetrahydrobiopterin
|
Drugbank
DB03963
|
S-(Dimethylarsenic)Cysteine
|
Drugbank
DB03974
|
|
Drugbank
DB04018
|
|
Drugbank
DB04223
|
|
Drugbank
DB04534
|
|
Drugbank
DB04559
|
N-(Chlorophenyl)-N'-Hydroxyguanidine
|
Drugbank
DB07001
|
(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f ...
|
Drugbank
DB07244
|
5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}- ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01833
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02048
|
1,2,4-Triazole-Carboxamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02335
|
|
Drugbank
DB02589
|
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02979
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetra ...
|
Drugbank
DB02994
|
Hydroxydimethylarsine Oxide
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03305
|
N5-Iminoethyl-L-Ornithine
|
Drugbank
DB03332
|
5,6-Cyclic-Tetrahydropteridine
|
Drugbank
DB03918
|
6s-5,6,7,8-Tetrahydrobiopterin
|
Drugbank
DB03963
|
S-(Dimethylarsenic)Cysteine
|
Drugbank
DB03974
|
|
Drugbank
DB04018
|
|
Drugbank
DB04223
|
|
Drugbank
DB04534
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66726
|
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66727
|
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66728
|
drug/chemical compound
NO
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66729
|
|
Drugbank entries
|
Show/Hide entries for
NOS2
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01110
|
|
Drugbank
DB01234
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02462
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
Drugbank
DB06879
|
5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H- ...
|
Drugbank
DB06916
|
N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-( ...
|
Drugbank
DB07002
|
4-({4-[(4-methoxypyridin-2-yl)amino]pipe ...
|
Drugbank
DB07003
|
(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1 ...
|
Drugbank
DB07007
|
(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7 ...
|
Drugbank
DB07008
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07011
|
(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4 ...
|
Drugbank
DB07029
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07306
|
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07318
|
N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQU ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07389
|
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL ...
|
Drugbank
DB07405
|
1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFL ...
|
Drugbank
DB08214
|
4-(1H-IMIDAZOL-1-YL)PHENOL
|
Drugbank
DB08750
|
1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H ...
|
Drugbank
DB08814
|
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66730
|
|
Drugbank entries
|
Show/Hide entries for
NOS2
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01110
|
|
Drugbank
DB01234
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02462
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
Drugbank
DB06879
|
5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H- ...
|
Drugbank
DB06916
|
N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-( ...
|
Drugbank
DB07002
|
4-({4-[(4-methoxypyridin-2-yl)amino]pipe ...
|
Drugbank
DB07003
|
(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1 ...
|
Drugbank
DB07007
|
(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7 ...
|
Drugbank
DB07008
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07011
|
(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4 ...
|
Drugbank
DB07029
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07306
|
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07318
|
N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQU ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07389
|
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL ...
|
Drugbank
DB07405
|
1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFL ...
|
Drugbank
DB08214
|
4-(1H-IMIDAZOL-1-YL)PHENOL
|
Drugbank
DB08750
|
1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H ...
|
Drugbank
DB08814
|
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66731
|
drug/chemical compound
NO
|
Drugbank entries
|
Show/Hide entries for
NOS2
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01110
|
|
Drugbank
DB01234
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02462
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
Drugbank
DB06879
|
5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H- ...
|
Drugbank
DB06916
|
N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-( ...
|
Drugbank
DB07002
|
4-({4-[(4-methoxypyridin-2-yl)amino]pipe ...
|
Drugbank
DB07003
|
(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1 ...
|
Drugbank
DB07007
|
(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7 ...
|
Drugbank
DB07008
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07011
|
(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4 ...
|
Drugbank
DB07029
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07306
|
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07318
|
N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQU ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07389
|
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL ...
|
Drugbank
DB07405
|
1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFL ...
|
Drugbank
DB08214
|
4-(1H-IMIDAZOL-1-YL)PHENOL
|
Drugbank
DB08750
|
1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H ...
|
Drugbank
DB08814
|
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66732
|
|
Drugbank entries
|
Show/Hide entries for
NOS3
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB00360
|
|
Drugbank
DB01110
|
|
Drugbank
DB01686
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01833
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02048
|
1,2,4-Triazole-Carboxamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02141
|
S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl)) ...
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02335
|
|
Drugbank
DB02589
|
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02911
|
2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydro ...
|
Drugbank
DB02979
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetra ...
|
Drugbank
DB02994
|
Hydroxydimethylarsine Oxide
|
Drugbank
DB03014
|
|
Drugbank
DB03065
|
7-Nitroindazole-2-Carboxamidine
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03305
|
N5-Iminoethyl-L-Ornithine
|
Drugbank
DB03332
|
5,6-Cyclic-Tetrahydropteridine
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03910
|
S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl)) ...
|
Drugbank
DB03918
|
6s-5,6,7,8-Tetrahydrobiopterin
|
Drugbank
DB03963
|
S-(Dimethylarsenic)Cysteine
|
Drugbank
DB03974
|
|
Drugbank
DB04018
|
|
Drugbank
DB04223
|
|
Drugbank
DB04534
|
|
Drugbank
DB04559
|
N-(Chlorophenyl)-N'-Hydroxyguanidine
|
Drugbank
DB07001
|
(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f ...
|
Drugbank
DB07244
|
5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}- ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01833
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02048
|
1,2,4-Triazole-Carboxamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02335
|
|
Drugbank
DB02589
|
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02979
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetra ...
|
Drugbank
DB02994
|
Hydroxydimethylarsine Oxide
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03305
|
N5-Iminoethyl-L-Ornithine
|
Drugbank
DB03332
|
5,6-Cyclic-Tetrahydropteridine
|
Drugbank
DB03918
|
6s-5,6,7,8-Tetrahydrobiopterin
|
Drugbank
DB03963
|
S-(Dimethylarsenic)Cysteine
|
Drugbank
DB03974
|
|
Drugbank
DB04018
|
|
Drugbank
DB04223
|
|
Drugbank
DB04534
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66733
|
|
Drugbank entries
|
Show/Hide entries for
NOS3
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB00360
|
|
Drugbank
DB01110
|
|
Drugbank
DB01686
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01833
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02048
|
1,2,4-Triazole-Carboxamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02141
|
S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl)) ...
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02335
|
|
Drugbank
DB02589
|
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02911
|
2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydro ...
|
Drugbank
DB02979
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetra ...
|
Drugbank
DB02994
|
Hydroxydimethylarsine Oxide
|
Drugbank
DB03014
|
|
Drugbank
DB03065
|
7-Nitroindazole-2-Carboxamidine
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03305
|
N5-Iminoethyl-L-Ornithine
|
Drugbank
DB03332
|
5,6-Cyclic-Tetrahydropteridine
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03910
|
S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl)) ...
|
Drugbank
DB03918
|
6s-5,6,7,8-Tetrahydrobiopterin
|
Drugbank
DB03963
|
S-(Dimethylarsenic)Cysteine
|
Drugbank
DB03974
|
|
Drugbank
DB04018
|
|
Drugbank
DB04223
|
|
Drugbank
DB04534
|
|
Drugbank
DB04559
|
N-(Chlorophenyl)-N'-Hydroxyguanidine
|
Drugbank
DB07001
|
(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f ...
|
Drugbank
DB07244
|
5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}- ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01833
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02048
|
1,2,4-Triazole-Carboxamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02335
|
|
Drugbank
DB02589
|
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02979
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetra ...
|
Drugbank
DB02994
|
Hydroxydimethylarsine Oxide
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03305
|
N5-Iminoethyl-L-Ornithine
|
Drugbank
DB03332
|
5,6-Cyclic-Tetrahydropteridine
|
Drugbank
DB03918
|
6s-5,6,7,8-Tetrahydrobiopterin
|
Drugbank
DB03963
|
S-(Dimethylarsenic)Cysteine
|
Drugbank
DB03974
|
|
Drugbank
DB04018
|
|
Drugbank
DB04223
|
|
Drugbank
DB04534
|
|
|
|
Comment
|
The NO-synthase enzymes are responsible for the synthesis of NO and this reaction occurs in all tissues. There are three different NOS families that differ in their level of expression and their localization: nNOS is mainly present in neural cells, iNOS in macrophages and eNOS in endothelial cells. All these enzymes share a common mechanism for synthesizing NO from arginine with release of citrulline, and require NADP+, FMN and biopterin as cofactors.
|
Formal Description Interaction-ID: 66734
|
drug/chemical compound
NO
|
Drugbank entries
|
Show/Hide entries for
NOS3
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB00360
|
|
Drugbank
DB01110
|
|
Drugbank
DB01686
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01833
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02048
|
1,2,4-Triazole-Carboxamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02141
|
S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl)) ...
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02335
|
|
Drugbank
DB02589
|
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02911
|
2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydro ...
|
Drugbank
DB02979
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetra ...
|
Drugbank
DB02994
|
Hydroxydimethylarsine Oxide
|
Drugbank
DB03014
|
|
Drugbank
DB03065
|
7-Nitroindazole-2-Carboxamidine
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03305
|
N5-Iminoethyl-L-Ornithine
|
Drugbank
DB03332
|
5,6-Cyclic-Tetrahydropteridine
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03910
|
S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl)) ...
|
Drugbank
DB03918
|
6s-5,6,7,8-Tetrahydrobiopterin
|
Drugbank
DB03963
|
S-(Dimethylarsenic)Cysteine
|
Drugbank
DB03974
|
|
Drugbank
DB04018
|
|
Drugbank
DB04223
|
|
Drugbank
DB04534
|
|
Drugbank
DB04559
|
N-(Chlorophenyl)-N'-Hydroxyguanidine
|
Drugbank
DB07001
|
(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f ...
|
Drugbank
DB07244
|
5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}- ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01833
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02048
|
1,2,4-Triazole-Carboxamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02335
|
|
Drugbank
DB02589
|
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02979
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetra ...
|
Drugbank
DB02994
|
Hydroxydimethylarsine Oxide
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03305
|
N5-Iminoethyl-L-Ornithine
|
Drugbank
DB03332
|
5,6-Cyclic-Tetrahydropteridine
|
Drugbank
DB03918
|
6s-5,6,7,8-Tetrahydrobiopterin
|
Drugbank
DB03963
|
S-(Dimethylarsenic)Cysteine
|
Drugbank
DB03974
|
|
Drugbank
DB04018
|
|
Drugbank
DB04223
|
|
Drugbank
DB04534
|
|
|
|